1. A Mutation-Sensitive Switch Assay to Detect Five Clinically Significant Epidermal Growth Factor Receptor Mutations
   Bin Liu et al, 2015, Genetic Testing and Molecular Biomarkers CrossRef
2. Differential responsiveness of MET inhibition in non-small-cell lung cancer with altered CBL
   Yi-Hung Carol Tan et al, 2017, Scientific Reports CrossRef
3. Molecular Docking Optimization in the Context of Multi-Drug Resistant and Sensitive EGFR Mutants
   María García-Godoy et al, 2016, Molecules CrossRef
4. Exon 19 deletion was associated with better survival outcomes in advanced lung adenocarcinoma with mutant EGFR treated with EGFR-TKIs as second-line therapy after first-line chemotherapy: a retrospective analysis of 128 patients
   Y. Wang et al, 2015, Clinical and Translational Oncology CrossRef